Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Research Institute of Medicine and Chemistry (RIMAC) was a private biochemistry and biotechnology company based in Cambridge, Massachusetts, founded in the late 1960s by Nobel Laureate Sir Derek Barton. The company specialized in the synthesis of complex organic molecules, with a significant focus on Vitamin D analogs and metabolites. RIMAC is historically notable for its pioneering work in the synthesis of 1-alpha-hydroxycholecalciferol (1-alpha-HCC), a potent Vitamin D3 analog. The company was involved in a high-profile legal dispute in the 1980s with the Wisconsin Alumni Research Foundation (WARF) over patent rights to Vitamin D synthesis methods. Following the settlement of this dispute in 1987, the company's operations largely ceased, and it is no longer active in the biotechnology sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Research Institute of Medicine.